SBI Securities’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152K Buy
49,437
+4,357
+10% +$14.8K ﹤0.01% 762
2026
Q1
$188K Sell
45,080
-2,864
-6% -$11.9K 0.01% 642
2025
Q4
$207K Sell
47,944
-4,525
-9% -$17.3K 0.01% 618
2025
Q3
$228K Sell
52,469
-1,708
-3% -$7.7K 0.01% 584
2025
Q2
$251K Buy
54,177
+37,623
+227% +$149K 0.01% 521
2025
Q1
$52.8K Buy
16,554
+10,092
+156% +$45.8K ﹤0.01% 957
2024
Q4
$35.9K Buy
+6,462
New +$44.1K ﹤0.01% 1089

Other funds holding SBC

SBI Securities's SBC Position: Q2 2026 in Review

SBI Securities increased its SBC Medical Group (SBC) stake by 9.7% in Q2 2026, buying an estimated $14.8K and bringing the position to 49,437 shares worth $152K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

SBI Securities first reported a position in SBC in Q4 2024 and has held it in 7 quarters since. The position peaked at $251K in Q2 2025. 12 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • SBI Securities held 49,437 shares of SBC Medical Group worth $152K as of Q2 2026.
  • SBI Securities bought 4,357 SBC Medical Group shares in Q2 2026, an estimated $14.8K.
  • SBC Medical Group made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #762 holding.
  • SBI Securities first reported a position in SBC Medical Group in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's SBC Medical Group position peaked at $251K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.